The Antifungal Treatment Market is expected to register a CAGR of 4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antifungal Treatment Market report covers segmental analysis by Drug Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines, Others); Therapeutic Indication (Systemic, Candidiasis, Coccidioidomycosis, Cryptococcosis, Prophylactic); Pathogen (Candida, Aspergillus, Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton, Others); End Users (Hospitals and Clinics, Dermatology Clinics, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Antifungal Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antifungal Treatment Market Segmentation
Drug Class- Azoles
- Pyrimidines
- Echinocandins
- Polyenes
- Allylamines
- Systemic
- Candidiasis
- Coccidioidomycosis
- Cryptococcosis
- Prophylactic
- Candida
- Aspergillus
- Cryptococcus
- Coccidioides Immitis
- Zygomycetes
- Trichophyton
- Hospitals and Clinics
- Dermatology Clinics
Strategic Insights
Antifungal Treatment Market Growth Drivers- Surge in Immunocompromised Populations: This includes the increasing immunocompromised subjects in the world, like cancer patients, HIV/AIDS patients, and recipients of organ transplants. The subjects are highly prone to fungal infection and thus require specific treatments. As the conditions are rising, the need for specific treatments in the antifungal therapy market is also expected to increase.
- Increasing Use of Topical Antifungal Products: The other important growth driver is the increasing demand for over-the-counter topical antifungal drugs for diseases such as athlete's foot, ringworm, and fungal nail infections. Topical treatments have the virtues of being handy, accessible, and easily available in a non-hospital setup. This trend of self-medication further increases the prospects for the topical antifungal product market to grow.
- Expansion of Healthcare Infrastructure in Developing Regions: The infrastructure of healthcare is rapidly improving in many developing regions, thereby improving access to the treatment of any medical problem, including antifungal therapy. Growing health expenditure, more advanced medical structures, and more awareness of the diseases empower a larger number of patients with adequate antifungal treatment, hence driving the demand for antifungal treatments in those regions and proving to be a growth-supporting market.
- Sustainability and Green Formulations: Pressure towards sustainability is slowly reaching the antifungal treatment market. Companies are under pressure to decrease their environmental impact, and therefore, consumption of "green" antifungal drugs, which are prepared from eco-friendly ingredients, biodegradable packaging, and sustainable manufacturing processes, is increasing. Consumers and regulators are demanding increasingly environmentally responsible products, and this will drive demand for the production and usage of green antifungal treatments.
- Increased Investment in Antifungal Resistance Research: Antifungal resistance development will also provoke greater investment in the research areas focusing on finding novel agents capable of overcoming mechanisms of resistance. The pharmaceutical companies already are investing massively with an outlook toward new, more potent drugs in the way of reversing the growing trend of resistance to antifungal treatment. The new research shall spark innovation in the Antifungal Treatment Market, creating a novel opportunity for breakthrough therapies.
- Telemedicine and Digital Health in Antifungal Treatment: Tomorrow telemedicine, and digital health platforms would further change the face of antifungal treatment administration. Virtual consultation with a healthcare provider using digital resources monitoring symptoms and adherence to the treatment can be very efficient in managing fungal infections. Technology integration in healthcare delivery makes access easier and accessible in the under-served and far-flung areas; thus increasing the Antifungal Treatment Market.
- Expansion of Over-the-Counter (OTC) Antifungal Options: Such easy accessibility enhances self-medication and leads to this huge potential of OTC antifungals. At present, these patients infected by diseases like ringworm, athlete's foot, and less virulent fungal infections of the nails look forward for over-the-counter treatments which are easy to use and more effective. It would be an excellent opportunity for the companies to develop and sell over-the-counter antifungals as the consumers, who have access to such remedies, are better equipped to be in control of their health.
- Collaborations and Strategic Partnerships: Bright innovation opportunity is there for the development of antifungals in strategic collaborations in pharmaceutical and bio-tech firms along with the research institutions. The time-to-market for new antifungal agents could be hastened, and the clinical trials may be initiated by companies other than expediting only the regulatory clearances through collaboration. Hence, by a partnership, they can pool their resources and capabilities and in the long run enhance the growth of the market other than making it more competitive in the arena of Antifungal Treatment Market.
- Increasing Focus on Fungal Infection Education: There is an ever-growing number of cases and is also underdiagnosed. Hence, the potential for more education and awareness campaigns on signs, symptoms, and treatment options for fungal infections is immense. Public health initiatives and partnerships with healthcare providers will help create awareness and make early diagnosis so that the need for antifungal treatments rises. The power of patients in receiving proper treatment at the right time through education enhances their outcome and helps in boosting market growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antifungal Treatment Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antifungal Treatment Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Antifungal Treatment Market is expected to register a CAGR of 4% from 2025-2031.
The major factors impacting the Antifungal Treatment Market are: Surge in Immunocompromised Populations, Increasing Use of Topical Antifungal Products and Expansion of Healthcare Infrastructure in Developing Regions
Key future trends in this market are - Sustainability and Green Formulations, Increased Investment in Antifungal Resistance Research and Telemedicine and Digital Health in Antifungal Treatment
Key companies of this market are: Sanofi S.A, Gilead Sciences, Inc., Pfizer Inc., Merck and Co., Inc., Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., Novartis International AG., GlaxoSmithKline Plc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antifungal Treatment Market - By Drug Class
1.3.2 Antifungal Treatment Market - By Therapeutic Indication
1.3.3 Antifungal Treatment Market - By Pathogen
1.3.4 Antifungal Treatment Market - By End Users
1.3.5 Antifungal Treatment Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIFUNGAL TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIFUNGAL TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIFUNGAL TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIFUNGAL TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ANTIFUNGAL TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIFUNGAL TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. AZOLES
7.3.1. Overview
7.3.2. Azoles Market Forecast and Analysis
7.4. PYRIMIDINES
7.4.1. Overview
7.4.2. Pyrimidines Market Forecast and Analysis
7.5. ECHINOCANDINS
7.5.1. Overview
7.5.2. Echinocandins Market Forecast and Analysis
7.6. POLYENES
7.6.1. Overview
7.6.2. Polyenes Market Forecast and Analysis
7.7. ALLYLAMINES
7.7.1. Overview
7.7.2. Allylamines Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. ANTIFUNGAL TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC INDICATION
8.1. OVERVIEW
8.2. THERAPEUTIC INDICATION MARKET FORECASTS AND ANALYSIS
8.3. SYSTEMIC
8.3.1. Overview
8.3.2. Systemic Market Forecast and Analysis
8.4. CANDIDIASIS
8.4.1. Overview
8.4.2. Candidiasis Market Forecast and Analysis
8.5. COCCIDIOIDOMYCOSIS
8.5.1. Overview
8.5.2. Coccidioidomycosis Market Forecast and Analysis
8.6. CRYPTOCOCCOSIS
8.6.1. Overview
8.6.2. Cryptococcosis Market Forecast and Analysis
8.7. PROPHYLACTIC
8.7.1. Overview
8.7.2. Prophylactic Market Forecast and Analysis
9. ANTIFUNGAL TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - PATHOGEN
9.1. OVERVIEW
9.2. PATHOGEN MARKET FORECASTS AND ANALYSIS
9.3. CANDIDA
9.3.1. Overview
9.3.2. Candida Market Forecast and Analysis
9.4. ASPERGILLUS
9.4.1. Overview
9.4.2. Aspergillus Market Forecast and Analysis
9.5. CRYPTOCOCCUS
9.5.1. Overview
9.5.2. Cryptococcus Market Forecast and Analysis
9.6. COCCIDIOIDES IMMITIS
9.6.1. Overview
9.6.2. Coccidioides Immitis Market Forecast and Analysis
9.7. ZYGOMYCETES
9.7.1. Overview
9.7.2. Zygomycetes Market Forecast and Analysis
9.8. TRICHOPHYTON
9.8.1. Overview
9.8.2. Trichophyton Market Forecast and Analysis
9.9. OTHERS
9.9.1. Overview
9.9.2. Others Market Forecast and Analysis
10. ANTIFUNGAL TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
10.1. OVERVIEW
10.2. END USERS MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. DERMATOLOGY CLINICS
10.4.1. Overview
10.4.2. Dermatology Clinics Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. ANTIFUNGAL TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Antifungal Treatment Market Overview
11.1.2 North America Antifungal Treatment Market Forecasts and Analysis
11.1.3 North America Antifungal Treatment Market Forecasts and Analysis - By Drug Class
11.1.4 North America Antifungal Treatment Market Forecasts and Analysis - By Therapeutic Indication
11.1.5 North America Antifungal Treatment Market Forecasts and Analysis - By Pathogen
11.1.6 North America Antifungal Treatment Market Forecasts and Analysis - By End Users
11.1.7 North America Antifungal Treatment Market Forecasts and Analysis - By Countries
11.1.7.1 United States Antifungal Treatment Market
11.1.7.1.1 United States Antifungal Treatment Market by Drug Class
11.1.7.1.2 United States Antifungal Treatment Market by Therapeutic Indication
11.1.7.1.3 United States Antifungal Treatment Market by Pathogen
11.1.7.1.4 United States Antifungal Treatment Market by End Users
11.1.7.2 Canada Antifungal Treatment Market
11.1.7.2.1 Canada Antifungal Treatment Market by Drug Class
11.1.7.2.2 Canada Antifungal Treatment Market by Therapeutic Indication
11.1.7.2.3 Canada Antifungal Treatment Market by Pathogen
11.1.7.2.4 Canada Antifungal Treatment Market by End Users
11.1.7.3 Mexico Antifungal Treatment Market
11.1.7.3.1 Mexico Antifungal Treatment Market by Drug Class
11.1.7.3.2 Mexico Antifungal Treatment Market by Therapeutic Indication
11.1.7.3.3 Mexico Antifungal Treatment Market by Pathogen
11.1.7.3.4 Mexico Antifungal Treatment Market by End Users
11.2. EUROPE
11.2.1 Europe Antifungal Treatment Market Overview
11.2.2 Europe Antifungal Treatment Market Forecasts and Analysis
11.2.3 Europe Antifungal Treatment Market Forecasts and Analysis - By Drug Class
11.2.4 Europe Antifungal Treatment Market Forecasts and Analysis - By Therapeutic Indication
11.2.5 Europe Antifungal Treatment Market Forecasts and Analysis - By Pathogen
11.2.6 Europe Antifungal Treatment Market Forecasts and Analysis - By End Users
11.2.7 Europe Antifungal Treatment Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Antifungal Treatment Market
11.2.7.1.1 Germany Antifungal Treatment Market by Drug Class
11.2.7.1.2 Germany Antifungal Treatment Market by Therapeutic Indication
11.2.7.1.3 Germany Antifungal Treatment Market by Pathogen
11.2.7.1.4 Germany Antifungal Treatment Market by End Users
11.2.7.2 France Antifungal Treatment Market
11.2.7.2.1 France Antifungal Treatment Market by Drug Class
11.2.7.2.2 France Antifungal Treatment Market by Therapeutic Indication
11.2.7.2.3 France Antifungal Treatment Market by Pathogen
11.2.7.2.4 France Antifungal Treatment Market by End Users
11.2.7.3 Italy Antifungal Treatment Market
11.2.7.3.1 Italy Antifungal Treatment Market by Drug Class
11.2.7.3.2 Italy Antifungal Treatment Market by Therapeutic Indication
11.2.7.3.3 Italy Antifungal Treatment Market by Pathogen
11.2.7.3.4 Italy Antifungal Treatment Market by End Users
11.2.7.4 Spain Antifungal Treatment Market
11.2.7.4.1 Spain Antifungal Treatment Market by Drug Class
11.2.7.4.2 Spain Antifungal Treatment Market by Therapeutic Indication
11.2.7.4.3 Spain Antifungal Treatment Market by Pathogen
11.2.7.4.4 Spain Antifungal Treatment Market by End Users
11.2.7.5 United Kingdom Antifungal Treatment Market
11.2.7.5.1 United Kingdom Antifungal Treatment Market by Drug Class
11.2.7.5.2 United Kingdom Antifungal Treatment Market by Therapeutic Indication
11.2.7.5.3 United Kingdom Antifungal Treatment Market by Pathogen
11.2.7.5.4 United Kingdom Antifungal Treatment Market by End Users
11.2.7.6 Rest of Europe Antifungal Treatment Market
11.2.7.6.1 Rest of Europe Antifungal Treatment Market by Drug Class
11.2.7.6.2 Rest of Europe Antifungal Treatment Market by Therapeutic Indication
11.2.7.6.3 Rest of Europe Antifungal Treatment Market by Pathogen
11.2.7.6.4 Rest of Europe Antifungal Treatment Market by End Users
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Antifungal Treatment Market Overview
11.3.2 Asia-Pacific Antifungal Treatment Market Forecasts and Analysis
11.3.3 Asia-Pacific Antifungal Treatment Market Forecasts and Analysis - By Drug Class
11.3.4 Asia-Pacific Antifungal Treatment Market Forecasts and Analysis - By Therapeutic Indication
11.3.5 Asia-Pacific Antifungal Treatment Market Forecasts and Analysis - By Pathogen
11.3.6 Asia-Pacific Antifungal Treatment Market Forecasts and Analysis - By End Users
11.3.7 Asia-Pacific Antifungal Treatment Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Antifungal Treatment Market
11.3.7.1.1 Australia Antifungal Treatment Market by Drug Class
11.3.7.1.2 Australia Antifungal Treatment Market by Therapeutic Indication
11.3.7.1.3 Australia Antifungal Treatment Market by Pathogen
11.3.7.1.4 Australia Antifungal Treatment Market by End Users
11.3.7.2 China Antifungal Treatment Market
11.3.7.2.1 China Antifungal Treatment Market by Drug Class
11.3.7.2.2 China Antifungal Treatment Market by Therapeutic Indication
11.3.7.2.3 China Antifungal Treatment Market by Pathogen
11.3.7.2.4 China Antifungal Treatment Market by End Users
11.3.7.3 India Antifungal Treatment Market
11.3.7.3.1 India Antifungal Treatment Market by Drug Class
11.3.7.3.2 India Antifungal Treatment Market by Therapeutic Indication
11.3.7.3.3 India Antifungal Treatment Market by Pathogen
11.3.7.3.4 India Antifungal Treatment Market by End Users
11.3.7.4 Japan Antifungal Treatment Market
11.3.7.4.1 Japan Antifungal Treatment Market by Drug Class
11.3.7.4.2 Japan Antifungal Treatment Market by Therapeutic Indication
11.3.7.4.3 Japan Antifungal Treatment Market by Pathogen
11.3.7.4.4 Japan Antifungal Treatment Market by End Users
11.3.7.5 South Korea Antifungal Treatment Market
11.3.7.5.1 South Korea Antifungal Treatment Market by Drug Class
11.3.7.5.2 South Korea Antifungal Treatment Market by Therapeutic Indication
11.3.7.5.3 South Korea Antifungal Treatment Market by Pathogen
11.3.7.5.4 South Korea Antifungal Treatment Market by End Users
11.3.7.6 Rest of Asia-Pacific Antifungal Treatment Market
11.3.7.6.1 Rest of Asia-Pacific Antifungal Treatment Market by Drug Class
11.3.7.6.2 Rest of Asia-Pacific Antifungal Treatment Market by Therapeutic Indication
11.3.7.6.3 Rest of Asia-Pacific Antifungal Treatment Market by Pathogen
11.3.7.6.4 Rest of Asia-Pacific Antifungal Treatment Market by End Users
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Antifungal Treatment Market Overview
11.4.2 Middle East and Africa Antifungal Treatment Market Forecasts and Analysis
11.4.3 Middle East and Africa Antifungal Treatment Market Forecasts and Analysis - By Drug Class
11.4.4 Middle East and Africa Antifungal Treatment Market Forecasts and Analysis - By Therapeutic Indication
11.4.5 Middle East and Africa Antifungal Treatment Market Forecasts and Analysis - By Pathogen
11.4.6 Middle East and Africa Antifungal Treatment Market Forecasts and Analysis - By End Users
11.4.7 Middle East and Africa Antifungal Treatment Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Antifungal Treatment Market
11.4.7.1.1 South Africa Antifungal Treatment Market by Drug Class
11.4.7.1.2 South Africa Antifungal Treatment Market by Therapeutic Indication
11.4.7.1.3 South Africa Antifungal Treatment Market by Pathogen
11.4.7.1.4 South Africa Antifungal Treatment Market by End Users
11.4.7.2 Saudi Arabia Antifungal Treatment Market
11.4.7.2.1 Saudi Arabia Antifungal Treatment Market by Drug Class
11.4.7.2.2 Saudi Arabia Antifungal Treatment Market by Therapeutic Indication
11.4.7.2.3 Saudi Arabia Antifungal Treatment Market by Pathogen
11.4.7.2.4 Saudi Arabia Antifungal Treatment Market by End Users
11.4.7.3 U.A.E Antifungal Treatment Market
11.4.7.3.1 U.A.E Antifungal Treatment Market by Drug Class
11.4.7.3.2 U.A.E Antifungal Treatment Market by Therapeutic Indication
11.4.7.3.3 U.A.E Antifungal Treatment Market by Pathogen
11.4.7.3.4 U.A.E Antifungal Treatment Market by End Users
11.4.7.4 Rest of Middle East and Africa Antifungal Treatment Market
11.4.7.4.1 Rest of Middle East and Africa Antifungal Treatment Market by Drug Class
11.4.7.4.2 Rest of Middle East and Africa Antifungal Treatment Market by Therapeutic Indication
11.4.7.4.3 Rest of Middle East and Africa Antifungal Treatment Market by Pathogen
11.4.7.4.4 Rest of Middle East and Africa Antifungal Treatment Market by End Users
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Antifungal Treatment Market Overview
11.5.2 South and Central America Antifungal Treatment Market Forecasts and Analysis
11.5.3 South and Central America Antifungal Treatment Market Forecasts and Analysis - By Drug Class
11.5.4 South and Central America Antifungal Treatment Market Forecasts and Analysis - By Therapeutic Indication
11.5.5 South and Central America Antifungal Treatment Market Forecasts and Analysis - By Pathogen
11.5.6 South and Central America Antifungal Treatment Market Forecasts and Analysis - By End Users
11.5.7 South and Central America Antifungal Treatment Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Antifungal Treatment Market
11.5.7.1.1 Brazil Antifungal Treatment Market by Drug Class
11.5.7.1.2 Brazil Antifungal Treatment Market by Therapeutic Indication
11.5.7.1.3 Brazil Antifungal Treatment Market by Pathogen
11.5.7.1.4 Brazil Antifungal Treatment Market by End Users
11.5.7.2 Argentina Antifungal Treatment Market
11.5.7.2.1 Argentina Antifungal Treatment Market by Drug Class
11.5.7.2.2 Argentina Antifungal Treatment Market by Therapeutic Indication
11.5.7.2.3 Argentina Antifungal Treatment Market by Pathogen
11.5.7.2.4 Argentina Antifungal Treatment Market by End Users
11.5.7.3 Rest of South and Central America Antifungal Treatment Market
11.5.7.3.1 Rest of South and Central America Antifungal Treatment Market by Drug Class
11.5.7.3.2 Rest of South and Central America Antifungal Treatment Market by Therapeutic Indication
11.5.7.3.3 Rest of South and Central America Antifungal Treatment Market by Pathogen
11.5.7.3.4 Rest of South and Central America Antifungal Treatment Market by End Users
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ANTIFUNGAL TREATMENT MARKET, KEY COMPANY PROFILES
13.1. PFIZER INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. SANOFI S.A.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GILEAD SCIENCES, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERCK AND CO., INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NOVARTIS INTERNATIONAL AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ABBOTT LABORATORIES
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BAYER AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. SCYNEXIS INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ENZON PHARMACEUTICALS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. GLAXOSMITHKLINE PLC
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Pfizer Inc
2. Sanofi S.A.
3. Gilead Sciences, Inc.
4. Merck and Co., Inc.
5. Novartis International AG
6. Abbott Laboratories
7. Bayer AG
8. Scynexis Inc.
9. Enzon Pharmaceuticals, Inc.
10. GlaxoSmithKline Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For